Characterization of the microVAScular Dysfunction in Covid-19 ARDS
NCT05074758
ARDS, Human, COVID-19 Acute Respiratory Distress Syndrome
Paris, France
View Trial DetailsNCT Number: NCT03807232
This retrospective study characterizes the clinical course and identifies four independent predictors of Acute Respiratory Distress Syndrome (ARDS) after burn injury (post-burn ARDS; pbARDS). In addition, a clinically useful prognostic score for pbARDS is introduced (ARDS burn score), which was derived from these independent predictors. The newly developed score may be helpful for the development of specific treatment strategies.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Rationale:
Acute Respiratory Distress Syndrome (ARDS) after burn injury (post-burn ARDS; pbARDS) is a severe complication associated with a mortality of up to 44%. To date, only few studies have been published on the clinical course and predictive factors of pbARDS.
Objectives:
To characterize the clinical course of pbARDS, to identify relevant predictors, including the development of a prognostic score, and to examine outcome parameters such as mortality and hospitalization days.
Methods:
A retrospective analysis of 400 patients admitted to the Burns Intensive Care Unit of the University Hospital Zurich from 2004 to 2009 was performed. Multivariate logistic regression was used to determine independent risk factors for pbARDS. A prognostic score was developed, which was tested with leave-one-out-cross-validation and Receiver Operating Characteristic (ROC) curves.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
all patients treated at the Burns Intensive Care Unit (BICU) of the University Hospital Zurich (USZ) between January 2004 and December 2009.
Exclusion criteria
Exclusions were made because of incomplete or unavailable data, re-hospitalization due to complications of previous burns, and the initial decision not to resuscitate due to unfavorable prognosis.
Time frame: 6 years
Number of patients who developed post-burn ARDS among 400 Patients admitted to Burns Intensive Care Unit of University Hospital Zurich
Time frame: 6 years
various clinical parameters related to the Outcome of post-burn-ARDS
Time frame: 6 years
To identify relevant predictors of post-burn ARDS, including the development of a prognostic score
Time frame: 6 years
A retrospective analysis of 400 patients admitted to the Burns Intensive Care Unit of the University Hospital Zurich
Time frame: 6 years
A retrospective analysis of 400 patients admitted to the Burns Intensive Care Unit of the University Hospital Zurich
University of Zurich
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05074758
ARDS, Human, COVID-19 Acute Respiratory Distress Syndrome
Paris, France
View Trial DetailsNCT04444609
ARDS, Human, COVID-19
London, United Kingdom
View Trial DetailsNCT05148026
ARDS, Human, Acute Kidney Injury
Monza, Italy
View Trial DetailsNCT04447833
ARDS, Human, COVID
Uppsala, Sweden
View Trial Details